May 2 (Reuters) – Pharmaceutical company Danco Laboratories filed an application with the U.S. Supreme Court on Saturday asking for a stay of an appeals court ruling that temporarily blocks mail-order access to abortion drug mifepristone.
(Reporting by Ismail Shakil and Tom Hals, Editing by Franklin Paul)
Comments